Susquehanna International Group’s iRadimed IRMD Stock Holding History

Susquehanna International Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.69M	Buy	27,981 +6,986	+33%	+$699K	﹤0.01%	5500
2025 Q4	$2.04M	Buy	20,995 +18,145	+637%	+$1.56M	﹤0.01%	5622
2025 Q3	$203K	Sell	2,850 -10,921	-79%	-$728K	﹤0.01%	10962
2025 Q2	$823K	Buy	13,771 +4,093	+42%	+$224K	﹤0.01%	7945
2025 Q1	$508K	Buy	9,678 +5,375	+125%	+$302K	﹤0.01%	8873
2024 Q4	$237K	Buy	+4,303	New	+$226K	﹤0.01%	10343
2024 Q1	–	Sell	-8,148	Closed	-$387K	–	12724
2023 Q4	$387K	Sell	8,148 -4,970	-38%	-$209K	﹤0.01%	9265
2023 Q3	$582K	Sell	13,118 -185	-1%	-$8.6K	﹤0.01%	7875
2023 Q2	$635K	Buy	13,303 +6,819	+105%	+$308K	﹤0.01%	7750
2023 Q1	$255K	Buy	+6,484	New	+$236K	﹤0.01%	10077

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's IRMD Position: Q1 2026 in Review

Susquehanna International Group increased its iRadimed (IRMD) stake by 33% in Q1 2026, buying an estimated $699K and bringing the position to 27,981 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #5500.

Susquehanna International Group first reported a position in IRMD in Q1 2023 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Susquehanna International Group held 27,981 shares of iRadimed worth $2.69M as of Q1 2026.
Susquehanna International Group bought 6,986 iRadimed shares in Q1 2026, an estimated $699K.
iRadimed made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5500 holding.
Susquehanna International Group first reported a position in iRadimed in Q1 2023 and has held it in 10 quarters since.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.